Abstract
From a patient, both a cell line incapable of secreting granulocyte colony-stimulating factor (G-CSF) (TC873) and a cell line capable of secreting G-CSF (TCM902) were established. The effector cells induced, with TC873 cells showed a high lytic capacity against two types of tumor cells. The effector cells induced by TCM902 cells did not show such capacity. Furthermore, the TCM902 cells excreted a factor suppressing the proliferation of lymphokine activated killer (LAK) cells and the autologous tumor cell lysis of tumor associated lymphocytes. This factor probably is TFG-β 1.
Similar content being viewed by others
Abbreviations
- CSF:
-
colony stimulating factor
- ELISA:
-
enzyme-linked immunosorbent assay
- G:
-
granulocyte
- GM:
-
granulocyte-monocyte
- IFN:
-
interferon
- IL:
-
interleukin
- LAK:
-
lymphokine activated killer
- M:
-
monocyte
- MLTC:
-
mixed lymphocyte tumor cell culture
- TGF:
-
transforming growth factor
- TILs:
-
tumor infiltrating lymphocytes
- TNF:
-
tumor necrosis factor
References
Asano S. Human granulocyte colony-stimulating factor: its basic aspects and clinical applications. Am J Pediatr Hematol Oncol 1991; 13: 400–13
Suzu S, Yokota H, Yamada M, Yanai N, Saito M, Kawashima T, Saito M, Takaku F, Motoyoshi K. Enhancing effect of human monocytic colony-stimulating factor on monocyte tumoricidal activity. Cancer Res 1989; 49: 5913–17
Okubo A, Sone S, Singh SM, Ogura T. Production of tumor necrosis factor-α by alveolar macrophages of lung cancer patients. Jpn J Cancer Res 1990; 81: 403–9
Tsuchiya Y, Igarashi M, Suzuki R, Kumagai K. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J Immunol 1988; 141: 699–708
Fu YX, Watson GA, Kasahara M, Lopez DM. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. J Immunol 1991; 146: 783–789
Anderson MR, Sassenfeld HM, Widmer MB. Interleukin 7 enhances cytolytic T lymphocyte generation and induces lymphokine activated killer cells from human peripheral blood. J Exp med 1990; 172: 577–587
Heo DS, Whiteside TL, Johnson JT, Chen K, Barnes EL, Herberman RB. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. Cancer Res 1987; 47: 6353–6362
Tanaka K, Ishikawa E, Ohmoto Y, Hirai Y.In vitro production of human interleukin 1α and interleukin 1β by peripheral blood mononuclear cells examined by sensitive sandwich enzyme immunoassay. Eur J Immunol 1987; 17: 1527–1530
Hanamura T, Motoyoshi K, Yoshida K, Saito M, Miura Y, Kawashima T, Nishida M, Takaku F. Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 1988; 72: 886–892
Nitoletti G, Brambilla P, Giovanni CD, Lollini PL, Del Re B, Marocchi A, Mocarelli P, Prodi G, Nanni P. Colony-stimulating activity from the new metastatic TS/ A cell lines and its high- and low-metastatic clonal deriviatives. Br J Cancer 1985; 52: 215–222
Aeed PA, Nakajima M, Welch DR. The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells. Int J Cancer 1988; 42: 748–759
Blanchard DK, Serbousek D, Djeu JY. Induction of human monocyte susceptibility to lymphokine-activated killer cell lysis by granulocyte-macrophage colonystimulating factor. Cancer Res 1989; 49: 5037–5043
Avalos BR, Gasson JC, Hedvat C, Quan SG, Baldwin GC, Weisbart RH, Williams RE, Golde DW, DiPersio JF. Human granulocyte colony-stimulating factor: biological activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Blood 1990; 75: 851–857
Baldwin GC, Golde DW, Widhopf GF, Economou J, Gasson JC. Identification and characterization of a low-affinity granulocyte-macrophage colony-stimulating factor receptor on primary and cultured human melanoma cells. Blood 1991; 78: 609–615
Segawa K, Ueno Y, Kataoka T.In vivo tumor growth enhancement by granulocyte colony-stimulating factor. Jpn J Cancer Res 1991; 440–447
Takeda K, Hyatakeyama K, Tsuchiya Y, Rikishi H, Kumagai K. A correlation between GM-CSF gene expression and metastases in murine tumors. Int J Cancer 1991; 47: 413–420
Young MRI, Lozano Y, Coogan M, Wright MA, Young ME, Bagash JM. Stimulation of the metastatic properties of Lewis-lung-carcinoma cells by autologous granulocytemacrophage colony-stimulating factor. Int J Cancer 1992; 50: 628–634
Mule JJ, Schwanz SL, Roberts AB, Sporn MB, Rosenberg SA. Transforming growth factor-beta inhibits thein vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunol Immunother 1988; 26: 95–100
Grotendorst GR, Smale G, Pencev D. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 1989; 140: 396–402
Tada T, Ohzeki S, Utsumi K, Takiuchi H, Muramatsu M, Li XF, Shimizu J, Fujiwara H, Hamaoka T. Transforming growth factor-β-induced inhibition of T cell function. J Immunol 1991; 146: 1077–1082
Takeda K, Fujii N, Nitta Y, Sakihara H, Nakayama K, Rikiishi H, Kumagai K. Murine tumor cells metastasizing selectively in the liver: ability to produce hepatocyteactivating cytokines interleukin-1 and/or -6. Jpn J Cancer Res 1991; 82: 1299–1308
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tsukuda, M., Nagahara, T., Mikami, Y. et al. A tumor cell line producing granulocyte colony-stimulating factor and an immune suppressive factor. Biotherapy 6, 217–223 (1993). https://doi.org/10.1007/BF01878083
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01878083